Shuttle Pharmaceuticals (SHPH) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free SHPH Stock Alerts $0.39 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024globenewswire.com - April 23 at 4:15 PMShuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024globenewswire.com - April 3 at 9:00 AMShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Fourth Quarter 2023 Corporate Updatefinanznachrichten.de - March 22 at 9:54 PMShuttle Pharma Provides Fourth Quarter 2023 Corporate Updatefinance.yahoo.com - March 22 at 9:54 PMSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q4 2023msn.com - March 22 at 8:02 AMShuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024globenewswire.com - March 5 at 9:00 AMShuttle Pharma Announces Its Intent to Pursue a Rights Offeringfinance.yahoo.com - February 13 at 8:19 AMShuttle Pharmaceuticals Acquires Promising Prostate Cancer Technologymsn.com - February 6 at 10:45 AMShuttle Pharmaceuticals Bolsters Investor Relations with New Partnershipmsn.com - February 6 at 10:45 AMShuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024finance.yahoo.com - January 23 at 4:36 PMShuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastomafinance.yahoo.com - January 8 at 1:12 PMShuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastomafinance.yahoo.com - December 11 at 12:56 PMShuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023finance.yahoo.com - November 30 at 10:44 AMShuttle Pharmaceuticals reports Q3 resultsmsn.com - November 14 at 1:52 PMShuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Updatefinance.yahoo.com - November 14 at 1:52 PMShuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreementfinance.yahoo.com - October 31 at 11:04 AMShuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor Conferencefinance.yahoo.com - October 10 at 10:46 AMShuttle Pharma Gets FDA Letter With Positive Feedback for Ropidoxuridinemarketwatch.com - September 25 at 12:38 PMShuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastomafinance.yahoo.com - September 25 at 12:38 PMShuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fairfinance.yahoo.com - September 13 at 11:48 AMShuttle Pharma Expands Patent Coverage on HDAC Inhibitor Platformfinance.yahoo.com - September 11 at 5:26 PMShuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer Therapeuticsfinance.yahoo.com - August 29 at 1:59 PMShuttle Pharmaceuticals Provides Second Quarter 2023 Corporate Updatefinance.yahoo.com - August 15 at 10:09 AMShuttle Pharmaceuticals (NASDAQ: SHPH)fool.com - August 11 at 5:32 AMShuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trialfinance.yahoo.com - August 3 at 3:15 PMShuttle Pharmaceuticals Q1 EPS $(0.07), Same YoYbenzinga.com - May 27 at 12:23 AMShuttle Pharmaceuticals Provides First Quarter 2023 Corporate Updatefinance.yahoo.com - May 26 at 9:21 AMShuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor Conferencefinance.yahoo.com - May 17 at 12:03 PMWhy Did Bullfrog AI Stock Jump More Than 50%? (SHPH)marketbeat.com - April 5 at 7:01 AMShuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidatesfinance.yahoo.com - March 22 at 12:38 PMShuttle Pharmaceuticals Engages UI Pharmaceuticals for Formulation and Clinical Batch Manufacture of Ropidoxuridine for Brain Tumor Clinical Trialfinance.yahoo.com - March 9 at 4:41 PMShuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic Capabilitiesfinance.yahoo.com - February 23 at 9:06 AMShuttle Pharmaceuticals making progress with Phase II clinical studyproactiveinvestors.com - February 6 at 4:45 PMShuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31finance.yahoo.com - January 27 at 9:33 AMSHPH Shuttle Pharmaceuticals Holdings, Inc.seekingalpha.com - January 25 at 1:54 PMShuttle Pharmaceuticals to Ring Nasdaq Opening Bell on Wednesday, January 18, 2023finance.yahoo.com - January 17 at 9:34 AMShuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and Warrantsfinance.yahoo.com - January 12 at 7:56 PMShuttle Pharmaceuticals Manuscript Published in Cancer Research Communicationsfinance.yahoo.com - December 6 at 3:43 PMRadiation therapy drug maker Shuttle Pharmaceuticals stock rockets 71%seekingalpha.com - December 3 at 10:44 AMShuttle Pharmaceuticals Provides Third Quarter 2022 Corporate Updatefinance.yahoo.com - November 15 at 11:44 AMShuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Studyfinance.yahoo.com - November 3 at 2:39 PMShuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directorsfinance.yahoo.com - November 1 at 10:43 AMShuttle Pharmaceuticals Holdings, Inc. (SHPH)ca.finance.yahoo.com - October 6 at 8:05 PMShuttle Pharmaceuticals Holdings Inc.wsj.com - September 22 at 6:26 AMShuttle Pharmaceuticals Enters into Manufacturing Agreement for Ropidoxuridinefinance.yahoo.com - September 20 at 2:02 PMShuttle Pharmaceuticals Stock (NASDAQ:SHPH), Analyst Ratings, Price Targets, Predictionsbenzinga.com - September 17 at 10:46 PMmarketbeat.com - September 16 at 11:06 AMmarketbeat.com - September 16 at 11:00 AMmarketbeat.com - September 16 at 10:46 AMmarketbeat.com - September 16 at 10:39 AM Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address The "Smart Money" Is Ready for May 1st Are You? (Ad)Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… SHPH Media Mentions By Week SHPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHPH News Sentiment▼0.000.43▲Average Medical News Sentiment SHPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHPH Articles This Week▼10▲SHPH Articles Average Week Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ENVB News HILS News ADXS News SBFM News UPC News AIMD News CVKD News XBIO News FWBI News TENX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SHPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
